TOP NEWS: Smith & Nephew Expects Revenue Hit From Virus Restrictions

(Alliance News) - Smith & Nephew PLC said it expects its fourth-quarter and full-year sales to be ...

Alliance News 11 January, 2021 | 8:29AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Smith & Nephew PLC said it expects its fourth-quarter and full-year sales to be hurt by Covid-19 restrictions, which resulted in surgical procedures being postponed.

The FTSE 100 medical devices manufacturer stated it expects to post a fourth-quarter underlying revenue decline of around 7.0%. It said sales were hurt by increased rates of Covid-19 infection from mid-October onwards, particularly in the US and Europe, as surgical procedures unconnected to the pandemic were postponed following the reintroduction of restrictions.

Smith & Nephew added that annual underlying revenue is expected to have declined by around 12%. The company reiterated trading profit margin will be substantially lower year-on-year, with negative operating leverage due to lower volumes partially offset by cost control measures.

It posted a trading profit margin of 22.8% in 2019 and revenue of USD5.14 billion.

Shares in Smith & Nephew were trading 2.9% lower at 1,572.50 pence each on Monday morning in London.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Smith & Nephew PLC 961.80 GBX -0.52

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures